IIRC they expect to reach 50+% ... maybe it could go up to 55-60%.
As we say: It is better to get fillérs (vents) often than forints (dollars) seldom ... (a bird in the hand is better than two in the bush)
I definitely agree with this strategy: (i) they stabilized the script# in this segment (meanwhile 15-20% decline in the other) (ii) still a good 70-75% gross profit (iii) maybe it could lead to the decision by the generics that they are not interested in gV anymore (I mean the 40-45% of a not too big market - due to early entry - will not be attractive enough for them.)